Michael Mano - Feb 28, 2023 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
SVP, General Counsel&Secretary
Signature
/s/Nancy Smith as Attorney-in-Fact for Michael Mano
Stock symbol
KPTI
Transactions as of
Feb 28, 2023
Transactions value $
-$20,835
Form type
4
Date filed
3/2/2023, 04:35 PM
Previous filing
Sep 1, 2022
Next filing
Sep 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Award $0 +70K +84.34% $0.00 153K Feb 28, 2023 Direct F1
transaction KPTI Common Stock Sale -$20.8K -6.88K -4.5% $3.03 146K Mar 1, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2024.
F2 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.